
Healthcare stays in flux as Congress passed an omnibus spending bill this past Friday, March 23, funding the federal government through September 2018.
While many healthcare provisions made their way into the budget, including increased funding for the opioid epidemic, the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC), there was no inclusion of a market stabilization bill for Affordable Care Act (ACA) marketplaces. The ACA stabilization package was introduced to attempt to drive down premium increases, which are expected to rise by about 30 percent in 2019 without stabilization measures.
Here are some top-line takeaways for healthcare within the $1.3 trillion omnibus spending bill:
ACCC is continuing to monitor how the most recent omnibus bill will affect cancer care providers and their patients. Stay tuned for updates as we continue to analyze this legislation.

At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
